Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Revisiting Notch in remyelination of multiple sclerosis lesions
Celia F. Brosnan, Gareth R. John
Celia F. Brosnan, Gareth R. John
Published December 22, 2008
Citation Information: J Clin Invest. 2009;119(1):10-13. https://doi.org/10.1172/JCI37786.
View: Text | PDF
Commentary

Revisiting Notch in remyelination of multiple sclerosis lesions

  • Text
  • PDF
Abstract

MS results from destruction of the protective myelin sheath surrounding axons, which prevents the transmission of nerve impulses. Precursors of oligodendrocytes, the cells capable of myelinating axons, are preserved in demyelinating lesions; however, why these precursors do not differentiate into mature oligodendrocytes and remyelinate axons is unknown. Contactin is a noncanonical Notch receptor ligand that mediates oligodendrocyte differentiation. In this issue of the JCI, Nakahara et al. show that Contactin is abundantly expressed on demyelinated axons in human chronic MS lesions and that Notch1 is activated in oligodendrocyte precursor cells (see the related article beginning on page 169). However, Notch1 intracellular domain coassociates with the nuclear transporter Importin β but fails to show evidence of nuclear translocation. These cytoplasmic aggregates also contain TAT-interacting protein 30 kDa (TIP30), a proapoptotic factor, which inhibits nuclear transport and, consequently, Notch1-mediated oligodendrocyte differentiation and remyelination. These data target TIP30 as a new pathogenic factor in MS.

Authors

Celia F. Brosnan, Gareth R. John

×

Total citations by year

Year: 2021 2018 2016 2015 2014 2013 2012 2011 Total
Citations: 1 2 2 2 1 2 2 2 14
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (14)

Title and authors Publication Year
Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.
Wang Y, Guo F
Biological reviews of the Cambridge Philosophical Society 2021
A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients: Therapeutic targets in multiple sclerosis
M Pazhouhandeh, MA Sahraian, SD Siadat, A Fateh, F Vaziri, F Tabrizi, F Ajorloo, AK Arshadi, E Fatemi, SP Gavgani, F Mahboudi, FR Jamnani
Clinical & Experimental Immunology 2018
N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination
X Yu, G Cheng, L Zhang, Y Zhang, Q Wang, M Zhao, L Zeng, Y Hu, L Feng
Scientific Reports 2018
Extracellular cues influencing oligodendrocyte differentiation and (re)myelination
NA Wheeler, B Fuss
Experimental Neurology 2016
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies
R Tognatta, RH Miller
Neuropharmacology 2016
Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
P Göttle, P Küry
International journal of molecular sciences 2015
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis
KA Chamberlain, SE Nanescu, K Psachoulia, JK Huang
Neuropharmacology 2015
Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury
A Pajoohesh-Ganji, MP Burns, S Pal-Ghosh, G Tadvalkar, NG Hokenbury, MA Stepp, AI Faden
Brain Research 2014
Remyelination therapy for multiple sclerosis
MB Keough, VW Yong
Neurotherapeutics 2013
Promoting return of function in multiple sclerosis: An integrated approach
M Gacias, P Casaccia
Multiple Sclerosis and Related Disorders 2013
Notch and Disease: a growing field
A Louvi, S Artavanis-Tsakonas
Seminars in Cell and Developmental Biology 2012
An overview of notch signaling in adult tissue renewal and maintenance.
Sato C, Zhao G, Ilagan MX
Current Alzheimer research 2012
Mediators of oligodendrocyte differentiation during remyelination
JR Patel, RS Klein
FEBS Letters 2011
TARGETING OLIGODENDROCYTE PROTECTION AND REMYELINATION IN MULTIPLE SCLEROSIS
J Zhang, EG Kramer, S Mahase, DJ Dutta, V Bonnamain, AT Argaw, GR John
The Mount Sinai journal of medicine, New York 2011

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts